Metal oxide nanoparticles (NPs), including zinc oxide (ZnO) NPs have shown success for use as vehicles for drug delivery and targeting gene delivery in many diseases like cancer. Current anticancer chemotherapeutics fail to effectively differentiate between cancerous and normal cells. There is an urgent need to develop novel drug delivery system that can better target cancer cells while sparing normal cells and tissues. Particularly, ZnO NPs exhibit a high degree of cancer cell selectivity and induce cell death, oxidative stress, interference with the cell cycle progression and genotoxicity in cancerous cells. In this scenario, effective cellular uptake of NP seems to be crucial, which is shown to be affected by cell cycle progression. In the present study, the cytotoxic potential of ZnO NPs and the effect of different cell cycle phases on the uptake of ZnO NPs were examined in A431 cells. It is shown that the ZnO NPs led to cell death and reactive oxygen species generation and were able to induce cell cycle arrest in S and G 2 /M phase with the higher uptake in G 2 /M phase compared with other phases.
Nanoparticles (NPs) are considered as a promising candidate in targeted therapies due to their improved bioavailability and specificity for application in several diseases including cancer (1, 2) . Therapeutic agent or drugs can be encapsulated within NPs or can be absorbed or conjugated onto their surface (3) . Applications of NPs as vehicles for drug delivery are currently an area of intense research. Current anticancer chemotherapeutics fail to produce a complete anticancer response due to the development of drug resistance or the failure to effectively differentiate between cancerous and normal cells (4) . Hence, it is imperative to develop a novel drug delivery system that can efficiently target the cancer cells while sparing normal cells and tissues.
A variety of metal oxide NPs have a good potential for their use as vehicle for drug delivery, targeted gene delivery and tumour imaging (5) . Use of zinc oxide (ZnO) NPs provides considerable promise in this domain, as ZnO NPs exhibit a high degree of cancer cell selectivity (5) (6) (7) (8) . ZnO NPs have multiple properties including favourable band gap, electrostatic charge, surface chemistry and potentiation of redox-cycling cascades that are useful for biomedical applications (5) . ZnO NPs have also found applications in areas of drug carrier and targeted gene delivery (9, 10) .
Earlier studies have shown that ZnO NPs induce cell death, oxidative stress, interfere with the cell cycle progression and genotoxicity in different organ-specific mammalian cell lines and in mice indicating their (11) (12) (13) (14) (15) inherent anticancer cytotoxic potential (5) . NPs can easily enter into the cell and interact with cellular system using energy dependent pathways (16) . Due to this behaviour, NPs interactions with biological systems were investigated for their potential to target tumour (17) .
Physico-chemical properties of NPs including size, shape, surface charge and surface chemistry play an important role in their cellular uptake (18) (19) (20) . The uptake of NPs in cells is also influenced by the different cell cycle phases (20) . The protein corona also plays an important role in the internalisation of NPs in the cells. Additionally, the interaction of NPs with cellular proteins is also dependent on cell cycle phases, as the expression of membrane proteins can vary during the cell cycle phases (21) . Earlier study from Kim et al. (20) have shown the effect of cell cycle phases on the cellular uptake of NPs using human lung carcinoma cells (A549) and carboxyl functionalised fluorescent tagged polystyrene NPs (PS-COOH) after 72 h. The uptake of NPs in the cells was observed maximum in G 2 /M and subsequently in S and G 0 /G 1 phase. It can be hypothesised from their observation that in cell cycle dependent targeted therapy, G 2 /M phase is more favourable to improve NP uptake.
In the present study, we investigated the effect of different cell cycle phases on the uptake of ZnO NPs. Instead of considering uptake in non-synchronised population, the cells were arrested in individual phases of cell cycle and ZnO NPs uptake was evaluated. Our data suggest that the ZnO NPs have higher uptake in G 2 /M and induce cell cycle arrest by activating the reactive oxygen species (ROS).
Materials and methods

Chemicals
Zinc oxide nanopowder (Cas No. PL-ZnO14-5g) was purchased from Reinste, Delhi, India. Phosphate buffered saline (PBS; Ca 2+ , Mg 2+ free), Dulbecco's Modified Eagles Medium (DMEM), antibioticantimycotic solution (10 000 U/ml penicillin, 10 mg/ml streptomycin and amphotericin-B), foetal bovine serum (FBS), Trypsin-EDTA, 2,5-diphenyltetrazolium bromide (MTT), neutral red (NR) dye, 2-7-dichlorofluorescein diacetate (DCF-DA) dye, propidium iodide (PI), Triton X-100, RNase, dimethyl sulphoxide (DMSO), thymidine were purchased from Hi-Media Pvt. Ltd, Mumbai, India. l-Mimosine and nocodazole were purchased from Sigma-Aldrich, St Louis, MO, USA. Tissue culture flasks (25 cm 2 ), 6-well plates and 96-well plates were purchased from Corning, India. Syringe filters (0.22 µm) and filter holders were purchased from Millipore Co. Pvt. Ltd, Mumbai, India. Syringe needles were purchased from Dispovan, India.
ZnO NPs preparation and characterisation
ZnO NPs were suspended in Milli-Q water and culture medium (DMEM + 10% FBS) at a concentration of 0.2 mg/ml, probe sonicated at 45 W for 10 min (2 min pulse on and 1 min pulse off). Hydrodynamic size and zeta potential of the stock suspension were determined by a Zeta Sizer Nano-ZS equipped with 4.0 mW, 633 nm laser (Model ZEN3600, Malvern, UK) instrument.
Cell culture and treatment of ZnO NPs
The human epidermal carcinoma cell line (A431) was obtained from National Centre for Cell Sciences, Pune, India, and cultured in DMEM supplemented with 10% FBS (heat inactivated), 0.2% sodium bicarbonate and 10 ml/L antibiotic and antimycotic solution, respectively at 37°C under a humidified atmosphere of 5% CO 2 .
Stock suspension of ZnO NPs (200 μg/ml) in DMEM (supplemented with 10% FBS) was serially diluted to concentrations ranging from 1 to 200 μg/ml (corresponding to 0.31-62.5 µg/cm 2 ) for cytotoxicity assays (MTT and NR uptake), cellular uptake, ROS generation, cell cycle progression analysis, etc. For each experiment, the particle suspension was freshly prepared, diluted to appropriate concentrations and immediately applied to the cells. For different assays 96-and 6-well culture plates having a treatment volume of 0.1 and 2 ml, respectively were used. Culture medium without ZnO NPs was served as the control in each experiment.
Cytotoxicity assay
Cytotoxicity of A431 cells after exposure to ZnO NPs was determined by MTT [3-(4, 5-dimethylthiazoyl-2-yl) 2, 5-diphenyltetrazolium bromide] assay and NR uptake assays. MTT assay is based on the mitochondrial activity and was done according to the method of Mosmann (22) . NR uptake assay is based on the accumulation of NR dye in the lysosomes of viable cells and was performed according to the method of Borenfreund and Puerner (23) with slight modification.
Briefly, 1 × 10 4 cells were seeded in 96-well plates and were maintained in culture media for 24 h. Cells were further exposed to different concentrations (1-200 µg/ml) of ZnO NPs for 6, 24 and 48 h. NP interference with the assay reagents was checked by incubating NPs with the assay reagents including dye and buffers using cell free system. The results were assessed by measuring the absorbance at their respective wavelengths using a SYNERGY-HT multiwell plate reader, Bio-Tek, USA using Gen5 software.
Intracellular ROS measurement
The level of intracellular ROS generation was estimated by the method of Wan et al. (24) further modified by Shukla et al. (25) using DCF-DA dye. Cells (3.0 × 10 5 cells/well) were seeded in a sixwell plate and were exposed to different concentration of ZnO NPs (10-80 μg/ml) for 6 h. The ZnO NPs containing media was aspirated and the cells were washed twice with 1× PBS. Cells were harvested using 0.25% trypsin-EDTA and then centrifuged at 135g for 5 min. The supernatant was discarded and the pellet was resuspended in 1 ml of PBS containing DCF-DA (20 μM) and incubated for 30 min at 37°C. The level of intracellular ROS was measured both by flow cytometer (FACSCalibur, BD Bioscience, CA, USA) and fluorescent microscope (Model DM 2500 Leica, Wetzlar, Germany).
Cell cycle progression analysis
The distribution of DNA in the cell cycle was studied by flow cytometer. About 3 × 10 5 cells/well were seeded in six-well cell culture plates. Cells were exposed to different concentrations of ZnO NPs (10-80 µg/ml) for 6, 24 and 48 h. The treatment was removed and cells were harvested and centrifuged at 135g for 10 min at 37°C. The pellet was fixed in ice-cold ethanol (70% in 1× PBS) and incubated at −20°C for 30 min. Cells were centrifuged and resuspended in lysis buffer (0.2% triton in 1× PBS) and incubated at 4°C for 30 min. Cells were further centrifuged and resuspended in 20 μg/ml RNase prepared in 1× PBS, incubated at 37°C for 30 min. Further cells were centrifuged and resuspended in 1× PBS and stained with 10 μl PI (1 mg/ml) followed by incubation at 4°C until analysis by flow cytometry (FACSCalibur, BD Bioscience).
Cellular uptake of ZnO NPs
A431 cells were seeded in six-well plates at a density of 3 × 10 5 cells/well. After 24 h of incubation, ZnO NPs of different concentrations (10-80 µg/ml) were added into the wells and incubated for 6 h. After exposure, NPs were removed and cells were harvested using 0.25% trypsin-EDTA. The supernatant was discarded and the pellet was resuspended in 500 µl of 1× PBS and the uptake of particles was determined using flow cytometer (FACSCalibur, BD Bioscience).
Cell synchronisation in different cell cycle phases G 0 /G 1 phase (mimosine block) About 1 × 10 5 cells per well were seeded in six-well cell culture plates and allowed to adhere for 24 h. Cells were then incubated with 500 µM mimosine prepared in DMEM (10% FBS) for 24 h. After incubation, cells were washed with 1× PBS and stained with PI and were analysed using flow cytometer (FACSCalibur, BD Bioscience).
S phase (double thymidine block) About 1 × 10 5 cells per well were seeded in six-well plate cell culture plates. Cells were incubated with 2 mM thymidine prepared in DMEM (10% FBS) for 19 h (First block). After first block, the thymidine was removed and DMEM + 10% FBS was added for 8 h to release cells. After releasing cells DMEM (10% FBS) + 2 mM thymidine were added for 18 h (second block). Finally, thymidine was removed by washing with 1× PBS. Cells were stained with PI and were analysed using flow cytometer (FACSCalibur, BD Bioscience). G 2 /M phase (nocodazole block) About 1 × 10 5 cells per well were seeded in six-well cell culture plates. Cells were incubated with DMEM (10% FBS) + 50 ng/ml nocodazole for 15 h. After treatment, media were removed and cells were washed with 1× PBS. Cells were stained with PI and analysed using flow cytometer (FACSCalibur, BD Bioscience).
Cellular uptake of ZnO NPs in different cell phases after synchronisation
Cells were seeded and pre-treated with different cell synchronising chemicals as described above. After removing the synchronising chemicals, ZnO NPs (40, 60 and 80 µg/ml) were added into wells and incubated for different time intervals (6 and 24 h). After exposure, NPs were removed and cells were harvested, and samples were prepared according to the method described in Cellular uptake of ZnO NPs.
Statistical analysis
Results from each experiment were expressed as mean ± SEM (standard error of mean) of three individual experiments and data were analysed using one-way analysis of variance (ANOVA). In all cases, P < 0.05 was considered as significant.
Results
Characterisation of ZnO NPs
The average hydrodynamic size and zeta potential of ZnO NPs in Milli-Q water were 215.8 ± 0.1 nm and −25.3 ± 0.4 mV, respectively. However, in DMEM medium (with 10% FBS) the hydrodynamic size and the zeta potential were 30.9 ± 0.5 nm and −12.8 ± 0.6 mV, respectively (Figure 1 ).
Evaluation of ZnO NP induced cytotoxicity
Cell viability assays were performed to assess the short-term, noncytotoxic concentration of ZnO NPs for A431 cells. Both MTT and NR uptake assays showing time and concentration dependent cytotoxicity of ZnO NPs in A431 cells.
MTT results demonstrated a statistically significant (P < 0.05) reduction in the mitochondrial succinate dehydrogenase enzymatic activity to 70.56% and 66.31% (relative to 100% of control) in cells exposed to ZnO NPs at concentration 100 and 200 µg/ml, respectively for 24 h. The reduction was further significant and reduced to 70.25%, 70.72%, 55.57% and 52.71% (relative to 100% of control) at 60, 80, 100 and 200 µg/ml concentrations, respectively after 48 h of exposure in human epidermal carcinoma (A431) cells. However, no significant cytotoxicity was observed in A431 cells after 6-h exposure (Figure 2A ).
In the NR uptake assay, a statistically significant (P < 0.05) reduction in %NR uptake was observed at two higher concentrations (100 and 200 µg/ml) of ZnO NPs. NR uptake was reduced to 65.83% and 42.32% after 6 h and 44.25% and 31.39% after 24 h and 39.28% and 8.09% after 48 h, demonstrating a high cytotoxic effect of ZnO NPs in A431 cells ( Figure 2B ).
Intracellular ROS generation
Our data showed that ZnO NPs induced oxidative stress in A431 cells as evident from the increased intracellular ROS. A significant 
Cell cycle analysis
ZnO NPs resulted in a decrease in number of cells in the G 1 phase and consequently a slight increase in number of cells in the S and G 2 /M phases. In A431 cells, ZnO NPs have also been shown to induce cell cycle arrest in S and G 2 /M phase in a concentration-dependent manner, however the data were not statistically significant (Figure 4 ).
Uptake of ZnO NPs
Using flow cytometry, we observed a statistically significant (P < 0.05) increase (151.48% and 257.03%) in the intensity of side scatter (SSC) of A431 cells after 6 h of ZnO NPs exposure to 40 and 80 μg/ml, relative to control cells (100%) ( Figure 5 ).
Synchronisation of cells
To evaluate the role of cell cycle on the cellular uptake of ZnO NPs, synchronisation of cells in different phases (G 0 /G 1 , S and G 2 /M) was done by different methods. Mimosine was used for G 0 /G 1 phase synchronisation; thymidine was employed for S phase synchronisation and nocodazole treatment was for G 2 /M phase cell synchronisation ( Figure 6 ).
In control population, the percent of cells in G 0 /G 1 phase was 50.65%. After mimosine treatment, the percent of cells that enter into G 0 /G 1 phase increased to 81.55%. Before treatment with thymidine, 29.09% cells were found in S phase which increased to 80.56% after treatment. The percent of cells in G 2 /M phase before and after treatment with nocodazole were found to be 31.37% and 90.21%, respectively.
Cellular uptake of ZnO NPs in different cell cycle phases
After the synchronisation of cells in different phases, the uptake of ZnO NPs was studied at different time intervals. Cells arrested in S and G 2 /M phase showed higher uptake than cells arrested in G 0 /G 1 phase after 6 h of ZnO NPs treatment. Difference in the uptake of ZnO NPs was also observed after 24 h of incubation. In G 0 /G 1 phase uptake of NPs was less as compared to other phases. Cells which were present in S phase had higher intracellular NPs concentration than cells in G 0 /G 1 phase and lower than the cells present in G 2 /M phase. From the results, it is evident that maximum NPs uptake is observed in G 2 /M phase followed by S phase and then in G 0 /G 1 phase: G 2 /M > S > G 0 /G 1 ( Figure 7 ; Table 1 ).
Discussion
In the present study, we investigated the cytotoxic potential and cell cycle dependent cellular uptake of ZnO NPs in A431 cells. Our data demonstrated that ZnO NPs are cytotoxic at high concentrations and generates oxidative stress due to increase in intracellular ROS, which could further lead to cell cycle arrest. We also observed cell cycle dependent cellular uptake of ZnO NPs in A431 cells.
Characterisation of NPs is the most essential part in nano-toxicological study. Dynamic light scattering (DLS) is considered as an indispensable tool for size characterisation as compared with other methods as it gives information for the stability of NPs in aqueous medium as well as the size is measured under conditions resembling the exposure scenarios. The size of ZnO NPs obtained in Milli-Q water and complete medium (DMEM + 10% FBS) were 215.8 and 30.9 nm, respectively. However, the size reported by its commercial supplier (Reinste) was 14 nm, as measured by transmission electron microscopy. The difference in the observed size of ZnO NPs is due to the different principles applied in the size measurement. Also, when NPs is exposed to biological medium, surface of NP gets coated with a layer of biomolecules especially proteins which forms 'protein corona'. In culture medium (DMEM + 10% FBS), ZnO NPs showed a small hydrodynamic size (30.9 nm) with a low zeta potential (−12.8 mV) because FBS forms a protein corona around the NPs which prevents the aggregation of NPs (26) (27) (28) (29) . Additionally, the protein corona plays an important role in the internalisation of NPs into the cells.
The cytotoxic potential of ZnO NPs was assessed using multiple assays, as it provides more reliable data while ignoring the interference of the dyes with NPs (30) (31) (32) (33) . A431 cells were exposed to ZnO NPs at different concentrations (1-200 μg/ml) and time points (6, 24 and 48 h). MTT and NR uptake assays were employed for cytotoxicity assessment. MTT represents mitochondrial activity and NR provides lysosomal activity of the cells. Both assays revealed a time and concentration dependent cytotoxicity of ZnO NPs, though with some variation. In MTT assay, the cytotoxicity appeared from 60 μg/ml concentration while NRU assay showed cytotoxicity from 100 μg/ml concentration. This is due to differences in the principles of both the cytotoxicity assays (30) . MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) is a yellow tetrazolium which gets reduced by metabolically active cells by the dehydrogenase enzymes and generates reducing equivalents such as NADH and NADPH. The resulting intracellular purple formazan is solubilised and quantified by spectrophotometric means while NR is a vital dye which is incorporated into the lysosomes by active transport whereas non-viable cells do not take up the dye. ROS plays a key role in a variety of physiological and cellular events including oxidative stress, apoptosis, protein and DNA damage (34) . We observed a significantly enhanced ROS production on exposure to ZnO NPs after 6 h in A431 cells. Because the NPs have small size, they can easily enter into the cells and can induce oxidative stress by generating free radicals (35) .
The internalisation of NPs was confirmed by flow cytometer and concentration-dependent increase in the SSC intensity of the treated cells. Increase in SSC intensity is an evidence of uptake of NPs (36) (37) (38) . We also compared the uptake of ZnO NPs in non-cancerous cell line HaCaT (human keratinocyte cell line) and we found almost similar uptake pattern in the uptake of ZnO NPs in cancerous (A431) and non-cancerous cells (HaCaT) ( Figure 7C) .
To study the difference in rate of uptake of NPs in different cell cycle phases, cell cycle progression was monitored after exposure to ZnO NPs. A schematic for the same is represented in Figure 8 . Cell cycle represents a series of events that allows cells to grow, proliferate and further protects the cells from DNA damage. Incubation of cells with ZnO NPs for 6, 24 and 48 h resulted in slight S and G 2 /M phase arrest in A431 cells. The cell cycle arrest represents a survival mechanism that provides an opportunity to the cancerous cells to repair its own DNA damage. However, induction of cell cycle arrest is often the basis of anticancer therapeutics (39) .
Earlier Kim et al. (20) discussed the role of cell cycle in NP uptake, and the uptake were ranked according to G 2 /M > S > G 0 / G 1 .The other properties of NPs such as size, shape, charge and the composition of protein corona also influences the cellular uptake of NPs (40) (41) (42) (43) . Once NPs enter into a biological fluid, their surface are coated with a layer of biomolecules such as proteins and lipids which demonstrated to have a key impact on the biological behaviour of NPs including cellular uptake (44) . NP-protein corona complex formation also depends on the cell cycle phases, because of the different expression of membrane proteins through the cell cycle phases which in turn affects cellular uptake (21) . Therefore, in this study we assessed the cell cycle-dependent cellular uptake of ZnO NPs in A431 cells. Cell cycle synchronisation was performed for evaluating the uptake of NPs by cells in different cell cycle phases. Our results indicated that cells in different phases of cell cycle showed a difference in the uptake of ZnO NPs in the order of: G 2 /M > S > G 0 /G 1 after 24 h of exposure. However, in case of 6 h exposure, the cellular uptake of the NPs were ranked as S > G 2 /M > G 0 /G 1 . At initial exposure time (6 h), cells synchronised in S and G 2 /M phase showed a higher uptake, whereas the cells synchronised in G 0 /G 1 phase showed lesser uptake as compared to S and G 2 /M phase. Greater differences started to appear once the cells had divided as observed after 24-h exposure of NPs. The cells in G 0 /G 1 phase showed a reduced NP uptake, as compared with other cells. This can be due to the difference in the incubation time of the NPs after cell division, as the cells in G 0 /G 1 phase have just divided and had less time to internalise the NPs. In G 2 /M phase cells have not yet divided, and therefore have accumulated NPs for longer time, whereas cells in S phase have accumulated NPs after cell division. Hence, it can be extrapolated from the observed data that in a cell population the concentration of internalised NPs varies through the cell cycle phases.
Cancerous cells are known to divide faster as compared with the normal counterparts, hence pass through the G 2 /M phase more frequently. Cancerous cells also exhibit higher uptake of NPs as compared with healthy cells. Higher uptake of silicon carbide bases NPs has been reported in cancer cells (HSC-2) as compared with non-cancerous cells (3T3-L1) (45) . NPs have bio-applications such as targeted therapies because they can cross biological barriers and distribute within cells by energy dependent pathway (1, 39, 46) . Many chemotherapeutics are known to affect the cell cycle distribution. For example, chemotherapeutic drugs (docetaxel and paclitaxel) arrest cells in G 2 /M phase and they are widely used in clinical field for the treatment of various cancers (47, 48) . Thus, a combined therapy, where one agent or compound (chemotherapeutic drug) arrest cells and the other deliver the therapy, can be exploited for enhanced tumour delivery of NPs.
Our results demonstrated that ZnO NPs induce cell death at high concentrations, and at lower concentrations they induce cell cycle arrest in S and G 2 /M phase by intracellular ROS generation in A431 cells. For therapeutics, the extent of cellular internalisation of the NPs must be controlled. The physiological characteristics of the NPs possess a significant role in NPs uptake. The present study also demonstrated that cell cycle progression affects cellular uptake of NPs in A431 cells. Thus from the study, a combined therapy can be proposed for treating complex diseases like cancer, in which one compound arrests cell division (G 2 /M phase arrest) and NPs delivers the drug or therapy.
